BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12148543)

  • 41. [Antiphospholipid antibodies in 146 women with repeated pregnancy losses].
    Ben Hadj Slama F; Nagara M; Slama A; Braham Jmili N; Monastiri K; Laouani-Kechrid C; Toumi NH; N'Siri B; Samama M; Mahjoub T
    Ann Biol Clin (Paris); 2004; 62(2):217-21. PubMed ID: 15047475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiphospholipid syndrome and recurrent miscarriages.
    Vinatier D; Dufour P; Cosson M; Houpeau JL
    Eur J Obstet Gynecol Reprod Biol; 2001 May; 96(1):37-50. PubMed ID: 11311759
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification and characterization of plasma kallikrein-kinin system inhibitors from salivary glands of the blood-sucking insect Triatoma infestans.
    Isawa H; Orito Y; Jingushi N; Iwanaga S; Morita A; Chinzei Y; Yuda M
    FEBS J; 2007 Aug; 274(16):4271-86. PubMed ID: 17645545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.
    Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F
    J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recurrent early pregnancy loss and antiphospholipid antibodies: where do we stand?
    Wong LF; Porter TF; de Jesús GR
    Lupus; 2014 Oct; 23(12):1226-8. PubMed ID: 25228711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of the kallikrein-kinin system and release of new kinins through alternative cleavage of kininogens by microbial and human cell proteinases.
    Imamura T; Potempa J; Travis J
    Biol Chem; 2004 Nov; 385(11):989-96. PubMed ID: 15576318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antineutrophil cytoplasmic antibodies and other immunologic abnormalities in patients with habitual abortion.
    Kovács L; Szabó J; Molnár K; Kovács A; Pokorny G
    Am J Reprod Immunol; 1999 Apr; 41(4):264-70. PubMed ID: 10374703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surface activation of blood coagulation, fibrinolysis and kinin formation.
    Heimark RL; Kurachi K; Fujikawa K; Davie EW
    Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological basis of fetoplacental antigenic determinants in the induction of the antiphospholipid antibody syndrome and recurrent pregnancy loss.
    Kwak JY; Beer AE; Cubillos J; Sandoval P; Mendoza JC; Espinel F
    Ann N Y Acad Sci; 1994 Sep; 731():242-5. PubMed ID: 7944127
    [No Abstract]   [Full Text] [Related]  

  • 51. Molecular assembly in the contact phase of the Hageman factor system.
    Cochrane CG; Griffin JH
    Am J Med; 1979 Oct; 67(4):657-64. PubMed ID: 386794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patho-physiology of kallikrein system.
    Colman RW
    Ann Clin Lab Sci; 1980; 10(3):220-6. PubMed ID: 6901589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiphospholipid and antioangiogenic activity in females with recurrent miscarriage and antiphospholipid syndrome.
    Pelusa HF; Pezzarini E; Basiglio CL; Musuruana J; Bearzotti M; Svetaz MJ; Daniele SM; Bottai H; Arriaga SM
    Ann Clin Biochem; 2017 Sep; 54(5):577-583. PubMed ID: 27638930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Down-regulation of maternal antiphospholipid antibodies during early pregnancy and pregnancy outcome.
    Kwak JY; Barini R; Gilman-Sachs A; Beaman KD; Beer AE
    Am J Obstet Gynecol; 1994 Jul; 171(1):239-46. PubMed ID: 8030706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Regulation of biological functions by the Kallikrein-Kinin system].
    Oh-Ishi S
    Yakugaku Zasshi; 1997 Nov; 117(10-11):739-48. PubMed ID: 9414587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who have negative test results for lupus anticoagulant and anticardiolipin antibodies.
    Silver RM; Pierangeli SS; Edwin SS; Umar F; Harris EN; Scott JR; Branch DW
    Am J Obstet Gynecol; 1997 Mar; 176(3):628-33. PubMed ID: 9077618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prevalence of antiphospholipid antibodies in cases of recurrent pregnancy loss.
    Chakrabarti S; Bhunia C; Bhattacharya DK
    J Assoc Physicians India; 1999 May; 47(5):496-8. PubMed ID: 10778558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Further characterization of monoclonal antibodies against rat plasma kallikrein, rat low molecular weight kininogen and synthetic bradykinin.
    Bedi GS; Back N
    Adv Exp Med Biol; 1989; 247B():223-30. PubMed ID: 2610064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specific antiphospholipid antibodies as a predictive variable in patients with recurrent pregnancy loss.
    Aoki K; Hayashi Y; Hirao Y; Yagami Y
    Am J Reprod Immunol; 1993 Mar; 29(2):82-7. PubMed ID: 8329109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abnormalities in the contact activation through factor XII in Fujiwara trait: a deficiency in both high and low molecular weight kininogens with low level of prekallikrein.
    Oh-ishi S; Ueno A; Uchida Y; Katori M; Hayashi H; Koya H; Kitajima K; Kimura I
    Tohoku J Exp Med; 1981 Jan; 133(1):67-80. PubMed ID: 6785899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.